http://www2.cochrane.org/reviews/en/ab004876.html">Effectiveness in seniors
Vaccines for preventing seasonal influenza and its complications in people aged 65 or older
Influenza vaccination of elderly individuals is recommended worldwide as people aged 65 and older are at a higher risk of complications, hospitalisations and deaths from influenza. This review looked at evidence from experimental and non-experimental studies carried out over 40 years of influenza vaccination. We included 75 studies. These were grouped first according to study design and then the setting (community or long-term care facilities). The results are mostly based on non-experimental (observational) studies, which are at greater risk of bias, as not many good quality trials were available. Trivalent inactivated vaccines are the most commonly used influenza vaccines.
Due to the poor quality of the available evidence, any conclusions regarding the effects of influenza vaccines for people aged 65 years or older cannot be drawn. The public health safety profile of the vaccines appears to be acceptable.
http://www2.cochrane.org/reviews/en/ab004876.html">Effectiveness in healthy children
Vaccines for preventing influenza in healthy children
...
The review authors found that in children aged from two years, nasal spray vaccines made from weakened influenza viruses were better at preventing illness caused by the influenza virus (82% of illnesses were prevented) than injected vaccines made from the killed virus (59%). Neither type was particularly good at preventing 'flu-like illness' caused by other types of viruses (33% and 36% respectively).
In children under the age of two, the efficacy of inactivated vaccine was similar to placebo. It was not possible to analyse the safety of vaccines from the studies due to the lack of standardisation in the information given but very little information was found on the safety of inactivated vaccines, the most commonly used vaccine, in young children. http://www2.cochrane.org/reviews/en/ab001269.html">Effectiveness in healthy adults
Vaccines to prevent influenza in healthy adults
...
Authors of this review assessed all trials that compared vaccinated people with unvaccinated people. The combined results of these trials showed that under ideal conditions (vaccine completely matching circulating viral configuration) 33 healthy adults need to be vaccinated to avoid one set of influenza symptoms.
In average conditions (partially matching vaccine) 100 people need to be vaccinated to avoid one set of influenza symptoms. Vaccine use did not affect the number of people hospitalised or working days lost but caused one case of Guillian-Barré syndrome (a major neurological condition leading to paralysis) for every one million vaccinations. Fifteen of the 36 trials were funded by vaccine companies and four had no funding declaration. Our results may be an optimistic estimate because company-sponsored influenza vaccines trials tend to produce results favorable to their products and some of the evidence comes from trials carried out in ideal viral circulation and matching conditions and because the harms evidence base is limited.
http://www2.cochrane.org/reviews/en/ab005187.html">Effectiveness in healthcare workers who work with the elderly
There are no accurate data on rates of laboratory-proven influenza in healthcare workers. The three studies in the first publication of this review and the two new studies we identified in this update are all at high risk of bias.
The studies found that vaccinating healthcare workers who look after the elderly in long-term care facilities did not show any effect on the specific outcomes of interest, namely laboratory-proven influenza, pneumonia or deaths from pneumonia. ...
Healthcare workers have lower rates of influenza vaccination than the elderly and
surveys show that healthcare workers who do not get vaccinated do not perceive themselves at risk, doubt the efficacy of influenza vaccine, have concerns about side effects, and some do not perceive their patients to be at risk. ...
We conclude that there is no evidence that only vaccinating healthcare workers prevents laboratory-proven influenza, pneumonia, and death from pneumonia in elderly residents in long-term care facilities. ...
http://www.cochrane.org/podcasts/issues-1-3-january-march-2010/two-updated-reviews-influenza-vaccines">Audio summary of effectiveness of influenza vaccines on the elderly and healthcare workers who work with the elderly
http://onlinelibrary.wiley.com/o/cochrane/clsysrev/articles/CD004876/frame.html">Full Text of Updated Study on Vaccines for Preventing Influenza in the Elderly
Authors' conclusions
The available evidence is of poor quality and provides no guidance regarding the safety, efficacy or effectiveness of influenza vaccines for people aged 65 years or older. To resolve the uncertainty, an adequately powered publicly-funded randomised, placebo-controlled trial run over several seasons should be undertaken.
http://www.cochrane.org/podcasts/influenza/summary-cochrane-reviews-influenza">Audio summary of the overall comparable effectiveness of all influenza preventatives and interventions